appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Aurobindo Pharma Ltd
AUROPHARMA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Buzzing Stocks: Yatra Online, Aurobindo Pharma, Dixon Tech, SJVN, others in news
3 days ago•Moneycontrol
Aurobindo Pharma Forays Into Indonesian Market With Brand Acquisitions
2 weeks ago•Bloomberg Quint
Aurobindo puts its injectables business on the block, again
1 month ago•Economic Times
Accumulate Aurobindo Pharma; target of Rs 907: KR Choksey
1 month ago•Moneycontrol
Why Lupin, Aurobindo Pharma, Cipla Are Top Stock Picks Of Analysts
1 month ago•Bloomberg Quint
Is Pharma back on growth track? Here’s why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma
1 month ago•Business Today
Alembic, Aurobindo recall drugs in US market
1 month ago•Economic Times
Alembic, Aurobindo Recall Drugs In US Market
1 month ago•Free Press Journal
Neutral Aurobindo Pharma; target of Rs 910: Motilal Oswal
1 month ago•Moneycontrol
JSW Energy, Aurobindo Pharma among 5 stocks with bearish RSI
1 month ago•Economic Times
Recent EventsAll events
Trading Window
Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Cash Dividend
Interim 1 • Div/Share: ₹ 3
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant